Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
I asked HHS to use its authority under existing law to break the patent monopoly on Leqembi if the manufacturers of this drug refuse to lower its price.
Simplified Text
Author asked HHS to break patent monopoly on Leqembi if manufacturers refuse to lower price.
Confidence Score
0.900
Claim Maker
The author
Context Type
Op-Ed
Context Details
{
    "drug": "Leqembi",
    "organization": "Health and Human Services (HHS)"
}
UUID
9fdb2e8b-7128-4173-8837-7f05f505b98b
Vector Index
✗ No vector
Created
September 12, 2025 at 12:34 AM (13 hours ago)
Last Updated
September 12, 2025 at 12:34 AM (13 hours ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.sanders.senate.gov/op-eds/the-greed-of-big-pharma-cannot-continue/
44 claims 🔥
13 hours ago
https://www.sanders.senate.gov/op-eds/the-greed-of-big-pharma-cannot-continue/

Senator Sanders criticizes exorbitant prescription drug prices in the US, highlighting the industry's lobbying power and advocating for price controls.

Pharmaceutical Industry
Healthcare Costs
Drug Pricing
Lobbying
US Politics
Medicare

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP